We appreciate the feedback on and constructive criticism of the CHAIN trial,1 where, as in all complex projects, there were various challenges, many of which were unforeseen. The result—an overall ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

In May, 2025, the World Health Assembly (WHA) will vote on re-establishing a mandate for WHO to address the health ...

For more than 80 years, the US Government has invested in biomedical, clinical, and public health research, making it a world leader in science and cutting-edge advances in health. These discoveries ...

Estimated energy requirements (EERs) are used every day for diverse purposes. In clinical care they provide the basis to plan ...

Mexico's type 2 diabetes crisis, with a prevalence of 16·9%, has made the country a focal point for fiscal policies targeting ...

Colombia's progressive drug policy reforms include the prioritisation of harm reduction, but campaigners fear advances are at risk. Jacqui Thornton reports.

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...